Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
Bartosz Hudzik, Editorial Consultant at JACC Case Reports, shared on LinkedIn:
”Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
In CV medicine, we often think of coronary artery disease as either acute (requiring urgent evascularization) or chronic (managed primarily with GDMT).
But there’s a critical group in between that doesn’t fit neatly into either category: subacute coronary occlusions (SCOs).
These lesions present unique diagnostic and therapeutic challenges.
Unlike acute coronary syndromes, they may not demand immediate intervention-but unlike stable chronic disease, delaying or misjudging treatment can lead to myocardial damage and worse outcomes.
This “gray zone” requires thoughtful, patient-centered decision-making that balances symptoms, ischemic burden, viability, and procedural risk.
A recent review takes a deep dive into this evolving space, outlining how SCOs differ from both acute and chronic occlusions and why a tailored approach is essential for optimal care.
Read the full article here.
Understanding where a patient lies along the spectrum of coronary occlusion can make all the difference-especially when the path forward isn’t black and white.”
Article: Subacute coronary artery occlusion: complexities of the grey zone
Authors: Michaella Alexandrou, Yader Sandoval, Fernando Alfonso, Emmanouil S Brilakis
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition
-
Apr 12, 2026, 14:18Jean Jacques Kiladjian: Grateful to the MSH for the invitation to ‘Highlights of ASH’ in Asia-Pacific 2026
-
Apr 12, 2026, 14:15Paritosh Garg: A fibrotic marrow is not always PMF
-
Apr 12, 2026, 14:13Scott Woller: ACC/AHA Guidelines and the Role of Pulmonary Embolism Response Teams
-
Apr 12, 2026, 13:55Ifeanyichukwu Ifechidere: When Fibrinogen isn’t Really Fibrinogen
-
Apr 12, 2026, 13:53Alan Nurden: A Contemporary Update on the Pathogenesis of Inherited Platelet Dysfunction
-
Apr 12, 2026, 13:47Kalyan Roy: Visual Inspection of Blood Bags and Blood Products
-
Apr 12, 2026, 13:44Francisco Ujueta: PAD VS CAD – Why Individualized Antithrombotic Strategies Matter
-
Apr 12, 2026, 13:42William Aird: Anemia of Inflammation Not Just a Trade-Off but a Possible Compensation